SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-15-000394
Filing Date
2015-01-28
Accepted
2015-01-27 17:34:46
Documents
18
Period of Report
2015-01-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gff8k_012715.htm 8-K 28239
2 EXHIBIT 99.1 exh_991.htm EX-99.1 14174
3 GRAPHIC exh991_01.jpg GRAPHIC 86426
4 GRAPHIC exh991_02.jpg GRAPHIC 189336
5 GRAPHIC exh991_03.jpg GRAPHIC 131935
6 GRAPHIC exh991_04.jpg GRAPHIC 131912
7 GRAPHIC exh991_05.jpg GRAPHIC 140776
8 GRAPHIC exh991_06.jpg GRAPHIC 143065
9 GRAPHIC exh991_07.jpg GRAPHIC 130823
10 GRAPHIC exh991_08.jpg GRAPHIC 153514
11 GRAPHIC exh991_09.jpg GRAPHIC 154479
12 GRAPHIC exh991_10.jpg GRAPHIC 181640
13 GRAPHIC exh991_11.jpg GRAPHIC 154888
14 GRAPHIC exh991_12.jpg GRAPHIC 161103
15 GRAPHIC exh991_13.jpg GRAPHIC 143697
16 GRAPHIC exh991_14.jpg GRAPHIC 125144
17 GRAPHIC exh991_15.jpg GRAPHIC 130416
18 GRAPHIC exh991_16.jpg GRAPHIC 86429
  Complete submission text file 0001171843-15-000394.txt   3139747
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
TEKMIRA PHARMACEUTICALS Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 15552623
SIC: 2834 Pharmaceutical Preparations